Literature DB >> 29589064

Recent major advances in cardiovascular pharmacotherapy.

James Milner1, Andreia Cunha2, Carlota Gamboa-Cruz2, Julie Reis2, Márcia Campos2, Natália António3,4.   

Abstract

The field of cardiovascular pharmacotherapy remains extremely active. The aim of this review is to summarize the recent major advances in cardiovascular pharmacotherapy, with a focus on (1) the new approved drug for treatment of heart failure with reduced ejection fraction-sacubitril/valsartan; (2) proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors; (3) the novel reversal agents for non-vitamin K oral anticoagulants (NOACs); and finally, (4) new evidence on pharmacological treatment of coronary artery disease.

Entities:  

Keywords:  Anticoagulation agents; Antidotes; Cardiovascular drugs; Coronary artery disease; Hypercholesterolemia; Systolic heart failure

Mesh：

Substances：

Year:  2018        PMID： 29589064     DOI： 10.1007/s00228-018-2453-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  58 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

Review 2.  Emerging biologic therapies for hypercholesterolaemia.

Authors:  Giacomo Pucci; Arrigo F Cicero; Claudio Borghi; Giuseppe Schillaci
Journal:  Expert Opin Biol Ther       Date:  2017-06-15       Impact factor: 4.388

Review 3.  Canakinumab for secondary prevention of atherosclerotic disease.

Authors:  Davide Capodanno; Dominick J Angiolillo
Journal:  Expert Opin Biol Ther       Date:  2017-12-27       Impact factor: 4.388

4.  Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease.

Authors:  Patrick H McNulty; Bryan J Robertson; Mark A Tulli; Joshua Hess; Lisa A Harach; Sofia Scott; Lawrence I Sinoway
Journal:  J Appl Physiol (1985)       Date:  2007-02-15

5.  Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Authors:  Paul M Ridker; James Revkin; Pierre Amarenco; Robert Brunell; Madelyn Curto; Fernando Civeira; Marcus Flather; Robert J Glynn; Jean Gregoire; J Wouter Jukema; Yuri Karpov; John J P Kastelein; Wolfgang Koenig; Alberto Lorenzatti; Pravin Manga; Urszula Masiukiewicz; Michael Miller; Arend Mosterd; Jan Murin; Jose C Nicolau; Steven Nissen; Piotr Ponikowski; Raul D Santos; Pamela F Schwartz; Handrean Soran; Harvey White; R Scott Wright; Michal Vrablik; Carla Yunis; Charles L Shear; Jean-Claude Tardif
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Authors:  Marianne Abifadel; Mathilde Varret; Jean-Pierre Rabès; Delphine Allard; Khadija Ouguerram; Martine Devillers; Corinne Cruaud; Suzanne Benjannet; Louise Wickham; Danièle Erlich; Aurélie Derré; Ludovic Villéger; Michel Farnier; Isabel Beucler; Eric Bruckert; Jean Chambaz; Bernard Chanu; Jean-Michel Lecerf; Gerald Luc; Philippe Moulin; Jean Weissenbach; Annick Prat; Michel Krempf; Claudine Junien; Nabil G Seidah; Catherine Boileau
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

8.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

Review 9.  Antidotes for novel oral anticoagulants: current status and future potential.

Authors:  Mark Crowther; Mark A Crowther
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-18       Impact factor: 8.311

Review 10.  Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia.

Authors:  Peter P Toth; Gillian Worthy; Shravanthi R Gandra; Naveed Sattar; Sarah Bray; Lung-I Cheng; Ian Bridges; Gavin M Worth; Ricardo Dent; Carol A Forbes; Sohan Deshpande; Janine Ross; Jos Kleijnen; Erik S G Stroes
Journal:  J Am Heart Assoc       Date:  2017-10-02       Impact factor: 5.501
View more
  1 in total

Review 1.  Impact of Diet and Exercise on Weight and Cognition in Older Adults: A Rapid Review.

Authors:  John A Batsis; Meredith N Roderka; Vanessa K Rauch; Lillian M Seo; Xingyi Li; Peter R DiMilia; Tyler Gooding; Diane Gilbert-Diamond; Auden C McClure; Robert M Roth
Journal:  Am J Health Promot       Date:  2021-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.